2020 ASCO Virtual Direct™ Highlights
2020 ASCO Melanoma Updates: Optimal Dosing Schedule of Neoadjuvant Ipi + Nivo, Adjuvant Pembro in Resected High-Risk Stage III, Adjuvant Dabrafenib + Trametinib in BRAF V600E Stage III, Pembro vs. Ipi in Advanced Melanoma
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ari VanderWalde
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ari VanderWalde
Login to view comments.
Click here to Login
